Rostami et al.
JOCArticle
2.7 (3H, s), 2.2 (m, 3H), 1.8 (m, 3H); 13C NMR (100 MHz,
DMSO-d6) 183.7, 165.6, 140.2, 131.1 (q, JC-F = 33 Hz), 122.7
(q, JC-F = 272 Hz), 118.9, 115.6, 16.9; HRMS (EI) calcd for
C20H8F12N2O2 536.0394, found m/z 536.0391.
(m), 1443 (s), 1206 (m), 1155 (m) cm-1; H NMR (400 MHz,
DMSO-d6) δ 9.9 (2H, s), 7.26 (4H, m), 6.96 (2H, dd, J = 8.0,
2.1 Hz), 6.66 (2H, dd, J = 8.0, 2.1 Hz); 13C NMR (100 MHz,
DMSO-d6) δ 181.5, 165.5, 160.1, 139.7, 130.2, 110.5, 109.0,
104.1, 55.1; HRMS (EI) calcd for C18H16N2O4 324.1110, found
m/z 324.1111.
1
3,4-Bis(phenylamino)cyclobut-3-ene-1,2-dione (1b). To a stir-
red solution of 3,4-diethoxycyclobut-3-ene-1,2-dione (81.3 μL,
0.55 mmol, 1.0 equiv) and zinc trifluoromethanesulfonate
(40 mg, 0.11 mmol, 20 mol %) in toluene/DMF 19:1 (1 mL)
was added aniline (92.6 μL, 1.15 mmol, 2.1 equiv). The solution
was heated to 100 °C and stirred for 12 h. When the solution was
cooled to room temperature, a white precipitate was observed
and isolated by decanting the solvent. The solid was further
washed with methanol (3 ꢀ 5 mL), and each time it was shaken
vigorously and centrifuged to remove the methanol yielding
1b as a white solid (138 mg, 0.52 mmol, 99% yield). The zinc
content of the isolated product was 0.02% as analyzed by ICP-
MS: IR (powder) 3134 (br), 1795 (w), 1666 (m), 1598 (m), 1534
3,4-Bis(2-nitrophenylamino)cyclobut-3-ene-1,2-dione (1g).
Synthesized on 0.1 mmol scale according to general procedure A,
the product was centrifuged, washed with pentane (3 ꢀ 5 mL),
and isolated as a red solid (69 mg, 98% yield): IR (powder) 3478
(br), 1785 (w), 1719 (w), 1605 (m), 1494 (m), 1433 (m), 1393 (m),
1249(s), 1034(m);1H NMR (400 MHz, DMSO-d6) δ10.6(2H, s),
8.16 (2H, dd, J = 8.4, 1.5 Hz), 7.77 (2H, ddd, J = 8.4, 7.4, 1.5
Hz), 7.58 (2H, dd, J =8.4, 1.5Hz), 7.4(2H, ddd, 8.5, 7.4, 1.5 Hz,);
13C NMR (100 MHz, DMSO-d6) δ 183.6, 166.3, 139.4, 134.8,
131.9, 125.5, 125.5, 124.8; HRMS (ESI) [M þ H]þ calcd for
C16H11N4O6 355.0673, found m/z 355.0682.
(s), 1448 (s) cm-1; the H NMR spectrum was in agreement
3,4-Bis(pyridin-2-ylamino)cyclobut-3-ene-1,2-dione (1h).
Synthesized on 0.1 mmol scale according to general procedure
A, the product was centrifuged, washed with methanol (3 ꢀ
5 mL), and isolated as a pale yellow solid (45 mg, 90% yield): IR
(powder) 3196 (w), 1797 (m), 1686 (m), 1605 (m), 1563 (m), 1475
1
with the previously reported spectrum:2 1H NMR (400 MHz,
DMSO-d6) δ 7.50 (4H, d, J = 7.3 Hz), 7.38 (4H, app t, J =
7.4 Hz), 7.90 (2H, app t, J = 7.4 Hz); 13C NMR (100
MHz, DMSO-d6) δ 181.5, 165.6, 138.5, 129.3, 123.2, 118.4;
HRMS (EI) calcd for C16H12N2O2 264.0899, found m/z
264.0896.
1
(m), 1362 (s), 1309 (s), 1148 (m), 772 (s) cm-1; H NMR (400
MHz, DMSO-d6) δ 11.6 (2H, s), 8.34 (2H, d, J = 5.0 Hz), 7.86
(2H, dd, J = 8.0, 1.9 Hz), 7.70 (2H, br s), 7.12 (2H, dd, J = 8.0,
5.0 Hz); 13C NMR (100 MHz, DMSO-d6) δ 183.4, 165.5, 151.4,
147.7, 139.4, 118.8, 112.7; HRMS (EI) calcd for C14H10N4O2
266.0804, found m/z 266.0806.
3,4-Bis(4-tert-butylphenylamino)cyclobut-3-ene-1,2-dione (1c).
Synthesized on 0.55 mmol scale according to general procedure
A, the productwas centrifuged, washedwithmethanol(3ꢀ 5 mL)
and isolated as a pale yellow solid (194 mg, 97% yield): IR
(powder) 3149 (br), 2951, 1790 (m), 1661 (m), 1598 (m), 1522
(s), 1428 (s), 1360 (s) cm-1; 1H NMR (400 MHz, DMSO-d6): δ
9.8 (2H, s), 7.40 (8H, m), 1.3 (18H, s); 13C NMR (100 MHz,
DMSO-d6) δ 181.3, 165.3, 145.7, 135.9, 126.0. 118.2, 34.0, 31.1;
HRMS (EI) calcd for C24H28N2O2 376.2151, found m/z
376.2141.
General Procedure B: Preparation of Squarate Monoesters.
3,4-Bis(4-bromophenylamino)cyclobut-3-ene-1,2-dione (1d).
Synthesized on 0.55 mmol scale according to general procedure
A, the product was centrifuged, washed with methanol (3 ꢀ
5 mL), and isolated as a pale yellow solid (210 mg, 99% yield): IR
(powder) 2942 (br), 1797 (m), 1657 (m), 1599 (m), 1528 (m), 1426
(s), 1399 (s), 1226 (m), 815 (s), 747 (s) cm-1; 1H NMR (400 MHz,
DMSO-d6) δ 9.9 (2H, s), 7.55 (4H, d, J = 9.0 Hz), 7.42 (4H, d,
J = 9.0 Hz); 13C NMR (100 MHz, DMSO-d6) partial (signal
corresponding to CdO was not observed) δ 165.5, 137.8, 132.1,
120.6, 115.3; HRMS (EI) calcd for C16H10N2O2Br2 419.9109,
found m/z 419.9100. Anal. Calcd for C16H10N2O2Br2: C, 45.53;
H, 2.39; N, 6.64. Found: C, 45.45; H, 2.53; N, 6.66.
3-(4-Bromophenylamino)-4-ethoxycyclobut-3-ene-1,2-dione
(3b). To a stirred solution of 3,4-diethoxycyclobut-3-ene-1,2-
dione (0.88 mL, 6.0 mmol, 1.2 equiv) and zinc trifluorometha-
nesulfonate (181 mg, 0.5 mmol, 10 mol %) in ethanol (15 mL)
at room temperature was added 4-bromoaniline (860 mg,
5.0 mmol, 1.0 equiv). After the solution was stirred for 1 h,
a white precipitate was formed, which was centrifuged to
remove the ethanol. The solid was further washed with
ethanol (3 ꢀ 5 mL), and each time it was centrifuged to
remove the ethanol yielding 3b as a white solid (1040 mg,
3.5 mmol, 70% yield): IR (powder) 3240 (w), 1790 (m), 1696
(m), 1603 (m), 1562 (m), 1501 (m), 1426 (s), 816 (m) cm-1; 1H
NMR (400 MHz, DMSO-d6) δ 10.82 (1H, s), 7.53 (2H, d, J =
8.2 Hz), 7.33 (2H, d, J = 8.2 Hz), 4.80 (2H, q, J = 7.0 Hz), 1.44
(3H, t, J = 7.0 Hz); 13C NMR (100 MHz, DMSO-d6) δ 187.5,
183.8, 178.5, 169.3, 137.4, 131.8, 121.4, 116.0, 69.6, 15.5;
HRMS (EI) calcd for C12H10BrNO3 294.9844, found m/z
294.9845. Anal. Calcd for C12H10BrNO3: C, 48.67; H, 3.40;
N, 4.73. Found: C, 47.95; H, 3.39; N, 4.62.
3-(4-Nitrophenylamino)-4-ethoxycyclobut-3-ene-1,2-dione (3c).
Synthesized on 2.0 mmol scale according to general procedure B,
the product was isolated as an orange solid (450 mg, 86% yield):
IR (powder) 3296 (w), 1802 (m), 1711 (m), 1620 (m), 1590 (m),
1504 (m), 1405 (m), 1297 (s), 1183 (s), 1097 (s), 986 (m) cm-1; 1H
NMR (400 MHz, DMSO-d6) δ 11.22 (1H, s), 8.23 (2H, d, 9.1 Hz),
7.59(2H, d, 9.1 Hz), 4.79(2H, q, 7.0Hz), 1.44 (3H, (2H, t, 7.0 Hz);
13C NMR (100 MHz, DMSO-d6) δ 187.0, 184.7, 179.9, 169.3,
144.3, 142.4, 125.2, 118.9, 70.1, 15.5; HRMS (ESI) [M þ H]þ for
C12H11N2O5 calcd 263.0662, found m/z 263.1. Anal. Calcd for
C12H10N2O5: C, 54.97; H, 3.84; N, 10.68. Found: C, 54.77; H,
3.82; N, 10.62.
3,4-Bis(4-methoxyphenylamino)cyclobut-3-ene-1,2-dione (1e).
Synthesized on 0.55 mmol scale according to general proce-
dure A, the product was centrifuged, washed with methanol (3
ꢀ 5 mL), and isolated as a pale yellow solid (180 mg, 94%
yield): IR (powder) 3113 (br), 1797 (w), 1661 (m), 1610 (w),
1554 (s), 1507 (s), 1451 (s), 1244 (m), 1178 (m), 1026 (m) cm-1
;
1
the H NMR spectrum was in agreement with the previously
reported spectrum:30 1H NMR (400 MHz, DMSO-d6) δ 9.7
(2H, s), 7.40 (4H, d, J = 8.7 Hz), 6.96 (4H, d, J = 8.7 Hz), 3.8
(6H, s); 13C NMR (100 MHz, DMSO-d6) δ 181.6, 164.9, 155.4,
131.6, 119.9, 114.3, 55.1; HRMS (EI) calcd for C18H16N2O4
324.1110, found m/z 324.1106. Anal. Calcd for C18H16-
N2O4: C, 66.66; H, 4.97; N, 8.64. Found: C, 66.15; H, 5.06;
N, 8.63.
3,4-Bis(3-methoxyphenylamino)cyclobut-3-ene-1,2-dione (1f).
Synthesized on 0.1 mmol scale according to general procedure
A, the product was centrifuged, washed with methanol (3 ꢀ
5 mL), and isolated as a pale yellow solid (59 mg, 90% yield): IR
(powder) 3007 (br), 1772 (w), 1646 (m), 1618 (m), 1598 (m), 1555
€
(30) Grunefeld, J.; Zinner, G. Arch. Pharm. (Weinheim) 1985, 318, 1062–
1070.
J. Org. Chem. Vol. 75, No. 12, 2010 3991